Rybelsus alternatives: the Ozempic pill and 8 other options, priced

The medication in brief

Why people look for alternatives

• The pharmacy cannot get Rybelsus

  With shipments to wholesalers stopped in May 2026, pharmacies are working through what is left (Illinois HFS notice). A new prescription is needed for any replacement, including the Ozempic pill, which uses different strengths.

• No self-pay Rybelsus price

  NovoCare Pharmacy lists self-pay prices for the Ozempic pill and pen, not for Rybelsus (NovoCare Pharmacy, checked 5 Oct 2026). Cash payers end up comparing the replacement with other drugs anyway.

• The morning fasting routine

  Both semaglutide tablets must be taken on an empty stomach with no more than 4 oz of plain water, then nothing else for 30 minutes (Rybelsus and Ozempic tablets label). Some people would rather inject once a week.

• Wanting a bigger effect on HbA1c or weight

  The Ozempic pen at 1 mg lowered HbA1c by 1.6 points over 30 weeks in its monotherapy trial (Ozempic label), and Mounjaro beat injected semaglutide head to head in SURPASS-2. No trial compares either directly with Rybelsus.

• Using it for weight, not diabetes

  Rybelsus has no weight-management indication. The Wegovy pill (semaglutide 25 mg) and Foundayo do, which matters for both the label and insurance.

How we compared

Prices checked on October 5, 2026

Alternatives

• Ozempic pill (semaglutide tablets 1.5, 4, 9 mg)

  Kind

  FDA-approved GLP-1

  How it differs

  The reformulated semaglutide tablet that replaces Rybelsus. Same label, same daily empty-stomach routine, different milligram strengths.

  Evidence

  Rybelsus and the Ozempic pill share one prescribing information, so the PIONEER trial results and the cardiovascular indication apply to both (Rybelsus and Ozempic tablets label). The label warns the two are not substitutable milligram for milligram. The Illinois notice reports Novo's suggested conversion: Rybelsus 7 mg to Ozempic 4 mg, and 14 mg to 9 mg. Your prescriber decides the actual dose.

  Starting price

  $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg, 30 tablets, self-pay (NovoCare Pharmacy, checked 5 Oct 2026)

  Best for

  Anyone stable on Rybelsus who wants to stay on daily oral semaglutide with the fewest changes

  Tradeoffs

  Needs a new prescription; Illinois Medicaid also requires a new prior authorization. Fasting rules are unchanged. Diabetes indication only.

• Ozempic pen (semaglutide injection)

  Kind

  FDA-approved GLP-1

  How it differs

  Semaglutide again, injected once a week instead of swallowed daily. No fasting window, but a needle.

  Evidence

  In a 30-week monotherapy trial on the Ozempic label, HbA1c fell 1.6 points on 1 mg and 1.4 on 0.5 mg, against 0.1 on placebo, and 70% to 73% of people reached an HbA1c under 7% (Ozempic label). Those are trial averages. The pen also carries indications for cutting cardiovascular risk and kidney disease progression in some adults with type 2 diabetes.

  Starting price

  Introductory $199 a month for two fills at 0.25 or 0.5 mg, then $349 (up to 1 mg) or $499 (2 mg) (NovoCare Pharmacy, checked 5 Oct 2026)

  Best for

  People who find the daily fasting routine hard to keep and are comfortable with a weekly injection

  Tradeoffs

  Costs more per month than the low-dose pill. Same thyroid C-cell boxed warning and GI side effects. Starts with its own dose escalation, set by your prescriber.

• Mounjaro (tirzepatide injection)

  Kind

  FDA-approved GLP-1

  How it differs

  A weekly GIP and GLP-1 dual agonist from Eli Lilly, approved for type 2 diabetes. A different molecule from semaglutide.

  Evidence

  SURPASS-2 compared Mounjaro with semaglutide 1 mg injection for 40 weeks in adults on metformin. HbA1c dropped 2.0 to 2.3 points across Mounjaro doses versus 1.9 on semaglutide, and body weight fell 7.6 to 11.2 kg versus 5.7 kg (Mounjaro label). The comparison was with injected, not oral, semaglutide. Averages only.

  Starting price

  As low as $499 a month with the Mounjaro Savings Card if you have commercial insurance that does not cover it (Mounjaro savings page, checked 5 Oct 2026)

  Best for

  Adults with type 2 diabetes whose HbA1c or weight goals were not met on oral semaglutide

  Tradeoffs

  The $499 card needs commercial insurance; uninsured cash prices are higher. Weekly injection. Same thyroid boxed warning as semaglutide.

• Generic liraglutide (Victoza equivalent)

  Kind

  FDA-approved GLP-1

  How it differs

  An older GLP-1 receptor agonist injected once a day. Available as a generic, which no form of semaglutide is.

  Evidence

  In a 52-week monotherapy trial on the Victoza label, HbA1c fell 1.1 points on 1.8 mg and 0.8 on 1.2 mg, versus 0.5 on glimepiride, and weight fell 2.5 kg and 2.1 kg versus a 1.1 kg gain (Victoza label). These are averages from one trial. Like semaglutide, it carries the thyroid C-cell boxed warning.

  Starting price

  $97.80 for a box of two 3 mL pens before shipping (Cost Plus Drugs price list, checked 5 Oct 2026); how long a box lasts depends on your dose

  Best for

  Cash payers with type 2 diabetes who want a GLP-1 at a generic price and can manage a daily injection

  Tradeoffs

  Daily rather than weekly injections. Smaller HbA1c and weight effects than semaglutide in its own trials.

• Metformin (generic)

  Kind

  FDA-approved other weight-loss drug

  How it differs

  Not a GLP-1 and not approved for weight loss. The long-standing first oral drug for type 2 diabetes, taken with meals.

  Evidence

  Metformin's label covers blood sugar control in type 2 diabetes. In the Diabetes Prevention Program, adults with raised blood sugar who took 850 mg twice a day developed diabetes 31% less often than those on placebo over an average 2.8 years (NEJM 2002). It carries a boxed warning for lactic acidosis, and kidney function guides its use.

  Starting price

  Thirty 500 mg tablets cost $5.32, or $10.57 once standard shipping is added (Cost Plus Drugs price list, checked 5 Oct 2026)

  Best for

  Adults with type 2 diabetes for whom cost matters most, often alongside another drug

  Tradeoffs

  Little effect on weight. Stomach upset and diarrhea are common early. Usually a base drug rather than a full replacement for semaglutide.

• Dapagliflozin (generic Farxiga)

  Kind

  FDA-approved other weight-loss drug

  How it differs

  An SGLT2 inhibitor tablet that lowers blood sugar by making the kidneys pass more glucose in urine. Not a GLP-1 and not a weight-loss drug.

  Evidence

  In a 24-week monotherapy trial on the Farxiga label, HbA1c fell 0.9 points on 10 mg against 0.2 on placebo. The label also covers lowering the risk of kidney decline and heart failure hospitalization in adults with chronic kidney disease or heart failure. Genital yeast infections occurred in 4.8% on 10 mg versus 0.9% on placebo (Farxiga label).

  Starting price

  $7.43 for 30 tablets of 10 mg before shipping (Cost Plus Drugs price list, checked 5 Oct 2026)

  Best for

  Adults with type 2 diabetes who also have heart failure or chronic kidney disease, or who want a once-daily pill with no fasting rule

  Tradeoffs

  Smaller HbA1c drop than semaglutide. Genital infections, dehydration and a rare risk of ketoacidosis are on the label.

• Wegovy pill (semaglutide 25 mg tablet)

  Kind

  FDA-approved GLP-1

  How it differs

  Daily oral semaglutide at a higher dose, approved for chronic weight management rather than blood sugar control.

  Evidence

  In a 64-week trial of adults with obesity or overweight and no diabetes (OASIS 4, Study 7 on the label), body weight fell 13.6% on the 25 mg tablet against 2.4% on placebo, and 59.8% lost at least 10% (Wegovy label). These are averages from one trial.

  Starting price

  $149 a month for 1.5 mg, rising to $299 for the 9 mg and 25 mg tablets, self-pay (NovoCare Wegovy price page, checked 5 Oct 2026)

  Best for

  People who took Rybelsus mainly for weight and want an oral semaglutide labeled for that purpose

  Tradeoffs

  Not a diabetes drug on its label. The same fasting routine applies. Coverage for weight management varies by plan.

• Foundayo (orforglipron tablet)

  Kind

  FDA-approved GLP-1

  How it differs

  A non-peptide daily GLP-1 pill from Lilly for weight management, taken with or without food. No fasting window.

  Evidence

  In the 72-week trial in adults with type 2 diabetes (Trial 2 on the label), weight fell 9.6% on 17.2 mg against 2.5% on placebo; without diabetes the figure was 11.1% against 2.1% (Foundayo label). Its label is for weight management, so it is not a direct replacement for diabetes treatment.

  Starting price

  $149 per 30 days at 0.8 mg (2.5 mg also $149 through 2026); regular price reaches $349 at 14.5 and 17.2 mg (Foundayo savings page, checked 5 Oct 2026)

  Best for

  Adults focused on weight who want a pill without the empty-stomach rule

  Tradeoffs

  No glycemic-control indication. Newest drug on this list. Higher doses cost more than the starting price.

• Compounded semaglutide pill or ODT

  Kind

  compounded (not FDA-approved)

  How it differs

  Semaglutide made by a 503A compounding pharmacy as a tablet or dissolving tablet, often with an added ingredient. Not Rybelsus and not FDA-approved.

  Evidence

  No trial has tested any compounded semaglutide tablet, so the PIONEER results on the Rybelsus label do not carry over. The FDA says compounded drugs are not reviewed for safety, effectiveness or quality before sale and should be used only when an FDA-approved drug cannot meet a patient's medical need (FDA, updated 1 Oct 2026). Temi calls it a separate, non-FDA-approved preparation.

  Starting price

  $85 for a 30-tablet pack (60 mg total) in California, with Temi's $39 fee on each order (Temi compounded semaglutide pill page, checked 5 Oct 2026)

  Best for

  Cash payers who have weighed the lack of FDA approval with a clinician and still want an oral option

  Tradeoffs

  No FDA approval, no label trials, and absorption of a compounded tablet is unstudied. Strengths do not map to Rybelsus or Ozempic tablet doses.

Which to choose

Switching